G16R (p.Gly16Arg) variant of VIM (Vimentin)

G16R (p.Gly16Arg) in VIM (Vimentin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data and structural context.

G16R (p.Gly16Arg) variant details